NeoCart

BIOLOGICAL2 trials

Sponsors

Histogenics Corporation

Conditions

Articular Cartilage DamageArticular Cartilage Defects in the Knee Joint

Phase 2

NeoCart Phase 2 Clinical Trial

CompletedNCT00548119

Histogenics CorporationArticular Cartilage Damage

Start: 2006-12-31End: 2014-03-31Updated: 2014-04-21

Phase 3

Confirmatory Study of NeoCart in Knee Cartilage Repair

TerminatedNCT01066702

Histogenics CorporationArticular Cartilage Defects in the Knee Joint

Start: 2010-05-31End: 2019-03-31Updated: 2019-03-29

Related Papers

Magnetic Resonance Imaging Characterization and Clinical Outcomes After NeoCart Surgical Therapy as a Primary Reparative Treatment for Knee Cartilage Injuries

The American Journal of Sports Medicine2017-01-0948 citations